BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22160733)

  • 21. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Spice" girls: synthetic cannabinoid intoxication.
    Schneir AB; Cullen J; Ly BT
    J Emerg Med; 2011 Mar; 40(3):296-9. PubMed ID: 21167669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
    Tait RJ; Caldicott D; Mountain D; Hill SL; Lenton S
    Clin Toxicol (Phila); 2016; 54(1):1-13. PubMed ID: 26567470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic cannabinoid use among college students.
    Mathews EM; Jeffries E; Hsieh C; Jones G; Buckner JD
    Addict Behav; 2019 Jun; 93():219-224. PubMed ID: 30772774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The "new" marijuana.
    Wells DL; Ott CA
    Ann Pharmacother; 2011 Mar; 45(3):414-7. PubMed ID: 21325097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic cannabinoid exposures reported to Texas poison centers.
    Forrester MB; Kleinschmidt K; Schwarz E; Young A
    J Addict Dis; 2011 Oct; 30(4):351-8. PubMed ID: 22026527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED.
    Yilmaz S; Karakayali O; Kale E; Akdogan A
    Am J Emerg Med; 2018 Mar; 36(3):435-441. PubMed ID: 28867154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic Cannabinoids.
    Mills B; Yepes A; Nugent K
    Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA.
    Dobaja M; Grenc D; Kozelj G; Brvar M
    Clin Toxicol (Phila); 2017 Mar; 55(3):193-195. PubMed ID: 28084855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis.
    Thornton SL; Lo J; Clark RF; Wu AH; Gerona RR
    Clin Toxicol (Phila); 2012 Dec; 50(10):1165-8. PubMed ID: 23163617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The other side of the leaf: Seizures associated with synthetic cannabinoid use.
    Gounder K; Dunuwille J; Dunne J; Lee J; Silbert P; Lawn N
    Epilepsy Behav; 2020 Mar; 104(Pt A):106901. PubMed ID: 31958643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signs and symptoms associated with synthetic cannabinoid toxicity: systematic review.
    Courts J; Maskill V; Gray A; Glue P
    Australas Psychiatry; 2016 Dec; 24(6):598-601. PubMed ID: 27558216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic cannabinoids as drugs of abuse.
    Ashton JC
    Curr Drug Abuse Rev; 2012 Jun; 5(2):158-68. PubMed ID: 22530798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A spicy status: Synthetic cannabinoid (spice) use and new-onset refractory status epilepticus-A case report and review of the literature.
    Babi MA; Robinson CP; Maciel CB
    SAGE Open Med Case Rep; 2017; 5():2050313X17745206. PubMed ID: 29238581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe Illness Associated with Reported Use of Synthetic Cannabinoids - Mississippi, April 2015.
    Kasper AM; Ridpath AD; Arnold JK; Chatham-Stephens K; Morrison M; Olayinka O; Parker C; Galli R; Cox R; Preacely N; Anderson J; Kyle PB; Gerona R; Martin C; Schier J; Wolkin A; Dobbs T
    MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(39):1121-2. PubMed ID: 26447715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geographic distribution of synthetic cannabinoid exposures reported to Texas poison centers.
    Forrester MB; Haywood T
    Am J Drug Alcohol Abuse; 2012 Nov; 38(6):603-8. PubMed ID: 22571605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural (∆
    Malyshevskaya O; Aritake K; Kaushik MK; Uchiyama N; Cherasse Y; Kikura-Hanajiri R; Urade Y
    Sci Rep; 2017 Sep; 7(1):10516. PubMed ID: 28874764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical presentation of intoxication due to synthetic cannabinoids.
    Cohen J; Morrison S; Greenberg J; Saidinejad M
    Pediatrics; 2012 Apr; 129(4):e1064-7. PubMed ID: 22430444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid induced behavioral convulsions in rabbits.
    Martin P; Consroe P
    Science; 1976 Nov; 194(4268):965-7. PubMed ID: 982057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic cannabinoid and marijuana exposures reported to poison centers.
    Forrester MB; Kleinschmidt K; Schwarz E; Young A
    Hum Exp Toxicol; 2012 Oct; 31(10):1006-11. PubMed ID: 22859662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.